(株)ミズホメディーの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証STD | 医薬品 | 4595/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2023/01/13 | 日証協 | 262,460株 | +0.54% | 20,600株 | +24.1% | 402,645株 | +1.62% | 28,809株 | -45.25% |
2023/01/06 | 日証協 | 261,060株 | +5.75% | 16,600株 | -73.75% | 396,238株 | +72.9% | 52,616株 | -78.37% |
2022/12/30 | 日証協 | 246,870株 | +18.86% | 63,250株 | +213.12% | 229,169株 | -21.05% | 243,283株 | +209.18% |
2022/12/23 | 日証協 | 207,700株 | -22.5% | 20,200株 | -78.71% | 290,253株 | -28.24% | 78,686株 | -18.48% |
2022/12/16 | 日証協 | 268,000株 | +43.55% | 94,900株 | +1760.78% | 404,456株 | -1.08% | 96,522株 | +5.01% |
2022/12/09 | 日証協 | 186,700株 | +1.08% | 5,100株 | -10.53% | 408,863株 | -4.84% | 91,913株 | +265.31% |
2022/12/02 | 日証協 | 184,700株 | -1.02% | 5,700株 | -81% | 429,655株 | +7.48% | 25,160株 | -75.87% |
2022/11/18 | 日証協 | 170,100株 | +33.73% | 198,800株 | +9999.99% | 411,276株 | -22.25% | 86,124株 | +95.27% |
2022/11/11 | 日証協 | 127,200株 | -8.13% | 1,960株 | -95.69% | 528,969株 | +2.3% | 44,104株 | +228.94% |
2022/11/04 | 日証協 | 138,460株 | -7.17% | 45,460株 | -67.47% | 517,073株 | -3.36% | 13,408株 | -72.01% |
2022/10/28 | 日証協 | 149,160株 | +7.96% | 139,768株 | -9.43% | 535,069株 | +0.35% | 47,900株 | +9.77% |
2022/10/21 | 日証協 | 138,160株 | +16.39% | 154,328株 | +75.17% | 533,192株 | +2.03% | 43,636株 | -38.73% |
2022/10/14 | 日証協 | 118,700株 | -52.03% | 88,104株 | +268.42% | 522,601株 | -1.52% | 71,216株 | +64.01% |
2022/10/07 | 日証協 | 247,460株 | -23.64% | 23,914株 | -79.23% | 530,676株 | -9.16% | 43,423株 | -53.66% |
2022/09/30 | 日証協 | 324,060株 | -3.05% | 115,146株 | +15.03% | 584,179株 | +4.08% | 93,710株 | -38.32% |
2022/09/22 | 日証協 | 334,260株 | +78.5% | 100,100株 | -34.66% | 561,257株 | +27.08% | 151,924株 | +289.46% |
2022/09/16 | 日証協 | 187,260株 | +3.6% | 153,200株 | +202.17% | 441,646株 | +1.85% | 39,009株 | -15.96% |
2022/09/09 | 日証協 | 180,760株 | -8.09% | 50,700株 | -51.71% | 433,643株 | +1.81% | 46,415株 | -37.87% |
2022/09/02 | 日証協 | 196,660株 | -13.31% | 105,000株 | +65.88% | 425,927株 | -1.36% | 74,712株 | +82.2% |
※株式分割は考慮していませんのでご注意ください。
Page Top